| Vision Mart Inc | |
|
12000 W Carmen Ave, Milwaukee, WI 53225-2116 | |
| (414) 462-1300 | |
| Not Available |
| Full Name | Vision Mart Inc |
|---|---|
| Type | Facility |
| Speciality | Technician/technologist - Optician |
| Location | 12000 W Carmen Ave, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366491227 | NPI | - | NPPES |
| 38450000 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| 156FX1800X | Technician/technologist - Optician | (* (Not Available)) | Primary |
| Provider Name | Paul R Herzfeld |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1417086901 PECOS PAC ID: 5799774329 Enrollment ID: I20040510000543 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Provider Name | Kristopher T Knous |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1356432199 PECOS PAC ID: 9335036664 Enrollment ID: I20041214000667 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Provider Name | Sara C Falter |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1265698187 PECOS PAC ID: 5395804389 Enrollment ID: I20081105000586 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Provider Name | Robert M Blankenbehler |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1700034931 PECOS PAC ID: 7911066089 Enrollment ID: I20100917000624 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Provider Name | Kurt A Haefs |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1578658068 PECOS PAC ID: 2062691918 Enrollment ID: I20110124001015 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Provider Name | Jessica M Bisgrove |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1114213261 PECOS PAC ID: 3476721416 Enrollment ID: I20110719000490 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Provider Name | Lisa M Peterson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1881988244 PECOS PAC ID: 1658541339 Enrollment ID: I20110907001434 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Provider Name | Yoseph Sarrafzadeh |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1265729222 PECOS PAC ID: 6002088044 Enrollment ID: I20111101000093 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Provider Name | Michael Douglas Rickels |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1124332283 PECOS PAC ID: 1456521590 Enrollment ID: I20150915002147 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Provider Name | Eric Tyler |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285652826 PECOS PAC ID: 2668367897 Enrollment ID: I20160323000843 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Provider Name | Ashley M Rak |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1497196059 PECOS PAC ID: 6709018286 Enrollment ID: I20160519001033 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Provider Name | Alwin A Edakkunnathu |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1467899609 PECOS PAC ID: 8123250776 Enrollment ID: I20170804002374 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vision Mart Inc 12000 W Carmen Ave, Milwaukee, WI 53225-2116 Ph: (414) 462-1300 | Vision Mart Inc 12000 W Carmen Ave, Milwaukee, WI 53225-2116 Ph: (414) 462-1300 |
News Archive
Neuropsychiatric issues have been frequently reported in coronavirus disease 2019 (COVID-19) long-haulers. A new study on the medRxiv* preprint server has found which neurological symptoms are likely to persist after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Dr Salman Siddiqui from the University of Leicester's Department of Infection, Immunity and Inflammation, will present his key PhD findings, 'Structure function Relationships in Adult Asthma' in a Doctoral Inaugural Lecture taking place on Wednesday 18 November.
The OBALON 3-Balloon System is the first and only ingestible, non-surgical, fully reversible, 6 month, FDA-approved balloon system and Ultimate Bariatrics is proud to be one of the first practices in Texas to offer this new tool in helping people achieve their weight loss goals.
A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.
› Verified 2 days ago